|
Press Releases |
|
|
|
Friday, March 1, 2024 |
|
Q&M Dental Group recorded growth in both Revenue and Net Profit after tax attributable to parent of S$182.7 million and S$11.5 million respectively for FY2023 |
more info >> |
|
Monday, September 11, 2023 |
|
Q&M Dental Group Sets the Gold Standard for Best Investor Relations at Singapore Corporate Awards |
Q&M Dental Group Limited is honoured to announce that it has received the prestigious "Best Investor Relations Award (Gold)" at the 18th Singapore Corporate Awards' ceremony held on 7 September 2023. The Award is given in recognition of Q&M Dental Group's commitment to maintaining transparency, communication, and excellence in investor relations. more info >> |
|
Tuesday, August 15, 2023 |
|
Q&M 1H2023 Core Healthcare Revenue stays resilient as the Group focuses on organic growth plans |
Mainboard-listed Q&M Dental Group (Singapore) Limited ("Q&M", the "Company", and together with its subsidiaries, the "Group") today reported total revenue of S$87.1 million, and profit after tax attributable to parent of S$5.3 million for the first half ended 30 June 2023 ("1H2023"). The Group's earnings before interest, tax, depreciation, amortisation ("EBITDA") for 1H2023 was S$18.5 million. more info >> |
|
Monday, July 10, 2023 |
|
Q&M Free Dental Clinic launched to provide free essential dental treatments for underprivileged individuals and families |
Q&M Free Dental Clinic Limited, a registered charity under the Commission of Charities, has opened its first Q&M Free Dental Clinic in Chai Chee dedicated to delivering essential dental treatment for underprivileged individuals and families in need. more info >> |
|
Friday, March 3, 2023 |
|
CATALIST-listed AOXIN Q&M reports lower revenue of RMB 140m for full year ended 31 December 2022 |
Catalist listed Aoxin Q&M Dental Limited, announced on 1 March 2023, a 12.8% lower revenue of RMB139.7 million for full year ended 31 December 2022 (FY2022). The Group reported a net loss after tax excluding impairment loss on investment in our associate of RMB7.3 million for FY2022, primarily due to the number of shutdowns from China's zero-Covid policy that was in place all the way up until 8 January 2023. more info >> |
|
Wednesday, March 1, 2023 |
|
Q&M reports lower full year profits due to impairments and decrease in Covid-19 related revenue |
Mainboard-listed Q&M Dental Group (Singapore) Limited today reported total revenue of S$181.2 million, and profit after tax attributable to parent (PATMI) of S$11.3 million for the twelve months ended 31 December 2022 (FY2022). The Group Earnings before interest, tax, depreciation, amortisation (EBITDA) for FY2022 was S$35.2 million. more info >> |
|
Friday, September 30, 2022 |
|
Q&M Group awards 7 Dentists with Performance Shares, 12-year Service Agreements, and a Private Placement |
Mainboard-listed Q&M Dental Group (Singapore) Limited announced on 29 September 2022 the award of 2,014,245 shares to 7 promising next-generation dentists as part of the Q&M Performance Share Plan (PSP) 2018, as well as the proposed placement of an additional 4,985,755 treasury shares, totalling S$1.75 million, through placement to the same dentists. more info >> |
|
Thursday, May 12, 2022 |
|
Q&M Dental net profit, excluding other gains or losses, increased by 25% to S$7.2 million on S$46.8 million of revenue for quarter ended 31 March 2022 |
Q&M Dental Group (Singapore) Limited, a leading private dental healthcare group in Asia, reported net profit excluding other gains or losses attributable to shareholders of S$7.2 million for the quarter ended 31 March 2022 (1Q2022) compared to S$5.8 million in the corresponding period (1Q2021). more info >> |
|
Wednesday, February 23, 2022 |
|
Q&M Dental records historic highest-ever revenue and profit after tax for year ended 31 December 2021 and declares a full year dividend yielding 7% |
Q&M Dental Group (Singapore) Limited ("Q&M" or together with its subsidiaries, the "Group"), a leading private dental healthcare group in Asia, today reported the highest-ever revenue and profit after tax of S$205.6 million and S$39.4 million respectively for the financial year ended 31 December 2021 ("FY2021"). more info >> |
|
Thursday, December 16, 2021 |
|
Acumen Diagnostics granted Ministry of Health COVID-19 offsite PCR testing license, up to 100 sites island-wide |
Homegrown medical technology Company, Acumen Diagnostics Pte. Ltd. ("Acumen Diagnostics" or the "Company"), a 51% owned subsidiary of Q&M Dental Group (Singapore) Limited ("Q&M Dental") and 49% owned by Aoxin Q&M Dental Group Limited ("Aoxin Q&M Dental"), today announced that it has been granted a license by the Ministry of Health, Singapore to provide offsite COVID-19 polymerase chain reaction ("PCR") swab services and serology sample collection. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Crown Digital Spearheads the Future of AI in F&B with Ella the Robobarista at AIM Global
Apr 18, 2024 17:00: JST
|
|
|
Mitsubishi Heavy Industries and NGK to Jointly Develop Hydrogen Purification System from Ammonia Cracking Gas
Apr 18, 2024 17:01 JST
|
|
|
Crown Digital Spearheads the Future of AI in F&B with Ella the Robobarista at AIM Global
Apr 18, 2024 16:00 HKT/SGT
|
|
|
ランドクルーザー、新型車"250"シリーズを発売
Apr 18, 2024 15:00: JST
|
|
|
Honda、「N-VAN」を一部改良し発売
Apr 18, 2024 15:00: JST
|
|
|
三菱重工と日本ガイシ、アンモニア分解ガスからの膜分離水素精製システムを共同開発
Apr 18, 2024 14:00: JST
|
|
|
Microex Launches Web3.0 Financial Trading Solution - Pioneering Innovation in Financial Technology
Apr 18, 2024 14:00 HKT/SGT
|
|
|
PAREMINAが革新的な抗老化ソリューションを携えて、Beautyworld Tokyo 2024でアジア初上陸を発表
Apr 18, 2024 13:45: JST
|
|
|
Toyota Launches All-New Land Cruiser "250" Series in Japan
Apr 18, 2024 13:39 JST
|
|
|
富士通とオラクル、日本市場におけるデータ主権要件に対応するソブリンクラウドの提供に向け戦略的協業
Apr 18, 2024 11:00: JST
|
|
|
Fujitsu and Oracle collaborate to deliver sovereign cloud and AI capabilities in Japan
Apr 18, 2024 11:14 JST
|
|
|
德事宣布2023年收入创新高
Apr 18, 2024 10:02 HKT/SGT
|
|
|
德事商務中心(TEC)2023年收入創新高
Apr 18, 2024 10:01 HKT/SGT
|
|
|
The Executive Centre Announces Record Revenue in FY2023 Annual Results
Apr 18, 2024 10:00 HKT/SGT
|
|
|
Eisai: Research on Treatments for Alzheimer's Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category)
Apr 18, 2024 10:53 JST
|
|
|
|
More News >> |
|
|
|
|
|